Does Levodopa Work for Multiple System Atrophy (MSA-P)?

If you have the Parkinsonian subtype of multiple system atrophy (MSA-P), medications like levodopa may provide some temporary relief, but they typically do not work as well or last as long as they do in Parkinson’s disease ^[1]. Research shows that about 30% of people with MSA-P experience a mild-to-moderate improvement in symptoms like muscle stiffness and tremors when starting levodopa ^[2][3]. However, this benefit usually fades within a few years ^[1][2].

Why Does the Benefit Fade?

To understand why levodopa eventually stops working, it helps to look at how the brain processes dopamine. In classic Parkinson’s disease, the brain stops producing enough dopamine, but the area that receives the dopamine—a region called the striatum—remains mostly healthy. Levodopa works by replacing the missing dopamine, which the healthy striatum can then use to help coordinate movement.

In MSA-P, the disease causes postsynaptic striatal degeneration ^[1][4]. This means that the striatum itself degenerates and loses its dopamine receptors, which are the specialized proteins that catch dopamine signals ^[5]. Even if levodopa successfully delivers extra dopamine to the brain, the damaged striatum can no longer receive or use the chemical signals effectively ^[2]. Because this degeneration is progressive, the medication’s benefits gradually wane as the disease advances ^[1][4].

What to Expect During a Levodopa Trial

Because individual responses can vary, your doctor will likely start you on a trial period of levodopa to observe how your body reacts ^[6]. During this trial, which typically lasts a few months, your doctor may need to prescribe higher doses of levodopa than what is normally used for Parkinson’s disease to see if it triggers a response. You and your care team will closely track whether there are meaningful improvements in your daily mobility, stiffness, or slowness ^[7].

Potential Side Effects to Watch For

Because doctors often need to use higher doses during an MSA-P trial, there are important side effects to monitor closely. Since MSA affects the autonomic nervous system (which controls automatic bodily functions like blood pressure), taking levodopa can sometimes worsen orthostatic hypotension ^[8][9]. This is a sudden, dizzying drop in blood pressure that happens when you stand up.

If you experience worsening dizziness or fainting spells, contact your doctor right away. Your care team can often help manage this by adjusting your other medications, recommending increased hydration, or prescribing compression garments so you can safely tolerate the levodopa trial ^[9].

Additionally, some people taking levodopa for MSA-P may develop dyskinesia, which refers to involuntary, jerky, or writhing movements ^[7]. In MSA, these movements can sometimes be especially noticeable in the face or neck area ^[7].

Your Long-Term Symptom Management Plan

If you are among the 30% who benefit from levodopa, it can be a helpful tool for managing stiffness early in your diagnosis ^[7][3]. As the disease progresses and the medication’s benefits eventually fade, your care team will help you taper off if it is no longer useful. They will also lean more heavily on other supportive strategies—such as physical therapy, occupational therapy, and specialized stretching routines—to help you manage stiffness and maintain your mobility and independence for as long as possible.